Audit 2703

FY End
2023-06-30
Total Expended
$63.34M
Findings
0
Programs
30
Year: 2023 Accepted: 2023-11-08

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.351 Research Infrastructure Programs $1.17M Yes 0
93.361 Nursing Research $400,762 Yes 0
47.049 Mathematical and Physical Sciences $134,213 Yes 0
93.839 Blood Diseases and Resources Research $111,905 Yes 0
93.121 Oral Diseases and Disorders Research $102,192 Yes 0
93.493 Congressional Directives $99,402 Yes 0
12.420 Military Medical Research and Development $94,726 Yes 0
93.855 Allergy, Immunology and Transplantation Research $91,504 Yes 0
93.859 Biomedical Research and Research Training $66,919 Yes 0
93.394 Cancer Detection and Diagnosis Research $65,657 Yes 0
93.113 Environmental Health $62,084 Yes 0
93.395 Cancer Treatment Research $56,149 Yes 0
93.396 Cancer Biology Research $55,547 Yes 0
93.837 Cardiovascular Diseases Research $54,827 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $44,552 Yes 0
93.279 Drug Abuse and Addiction Research Programs $43,957 Yes 0
93.838 Lung Diseases Research $42,654 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $40,182 Yes 0
93.398 Cancer Research Manpower $32,849 Yes 0
93.397 Cancer Centers Support Grants $32,161 Yes 0
47.070 Computer and Information Science and Engineering $31,730 Yes 0
93.307 Minority Health and Health Disparities Research $31,568 Yes 0
93.213 Research and Training in Complementary and Integrative Health $25,178 Yes 0
93.242 Mental Health Research Grants $22,681 Yes 0
93.866 Aging Research $10,040 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $9,210 Yes 0
47.084 Nsf Technology, Innovation, and Partnerships $8,493 Yes 0
93.103 Food and Drug Administration_research $8,457 Yes 0
93.399 Cancer Control $2,792 Yes 0
93.393 Cancer Cause and Prevention Research $2,492 Yes 0

Contacts

Name Title Type
DVHKP4N619V9 Virginia Perez Auditee
8137456498 Richard Sacher Auditor
No contacts on file

Notes to SEFA

Title: NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. he accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. Reporting Entity Uniform Guidance, Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General, set forth the audit and reporting requirements for federal awards and state financial assistance. The Schedule includes all federal and state awards expended by the Cancer Center. Basis of Accounting The Schedule has been prepared using the accrual basis of accounting. The accrual basis of accounting recognizes revenues when they are earned and expenditures when the related liability is incurred.
Title: NOTE 2 - INDIRECT COST RATE Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. The Cancer Center did not use the 10% de minimis indirect cost rate allowed by the Uniform Guidance.
Title: NOTE 3 - CONTINGENCIES Accounting Policies: The accounting policies and presentation of the Schedule of Expenditures of Federal Awards and State Financial Assistance (the Schedule) of H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries (the Cancer Center) have been designed to conform to accounting principles generally accepted in the United States and the reporting and compliance requirements of Title 2 U.S. Code of Federal Regulation (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Section 215.97, Florida Statutes, and Chapter 10.650, Rules of the Auditor General. De Minimis Rate Used: N Rate Explanation: Nonprofit rate agreement in place at the time of the award. Grant monies received and disbursed by the Cancer Center are for specific purposes and are subject to audit by the grantor agencies. Such audits may result in requests for reimbursement due to disallowed expenditures. Based upon prior experience, the Cancer Center does not believe that such disallowances, if any, would have a material effect on the financial position of the Cancer Center. As of September 29, 2023, there were no material questioned or disallowed costs as a result of grant audits in process or completed of which management is aware.